Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Bugarski-Kirola · SciRah

Researcher profile · Semantic Scholar

D. Bugarski-Kirola

Share profile

D. Bugarski-Kirola — researcher profile on SciRah

h-index: 12
Works: 47
Citations: 1,220

Most-cited papers

Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data.
J. Rabinowitz, S. Levine, George Garibaldi, D. Bugarski-Kirola +2 more
2012Schizophrenia Research376 citations
Semantic Scholar
Bitopertin in Negative Symptoms of Schizophrenia-Results From the Phase III FlashLyte and DayLyte Studies.
D. Bugarski-Kirola, T. Blaettler, C. Arango, W. Fleischhacker +10 more
2017Biological Psychiatry136 citations
Semantic Scholar
Association of prominent positive and prominent negative symptoms and functional health, well-being, healthcare-related quality of life and family burden: a CATIE analysis.
J. Rabinowitz, C. G. Berardo, D. Bugarski-Kirola, S. Marder
2013Schizophrenia Research118 citations Open access
Semantic Scholar
Effects of D-cycloserine on negative symptoms in schizophrenia.
E. Duncan, Sándor Szilágyi, Marion P. Schwartz, D. Bugarski-Kirola +9 more
2004Schizophrenia Research94 citations
Semantic Scholar
A phase II/III trial of bitopertin monotherapy compared with placebo in patients with an acute exacerbation of schizophrenia - results from the CandleLyte study.
D. Bugarski-Kirola, A. Wang, D. Abi‐Saab, T. Blättler
2014European Neuropsychopharmacology93 citations
Semantic Scholar
Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial p
D. Bugarski-Kirola, N. Iwata, S. Sameljak, Carol Reid +5 more
2016Lancet psychiatry65 citations
Semantic Scholar
Prepulse inhibition of acoustic startle in subjects with schizophrenia treated with olanzapine or haloperidol.
E. Duncan, Sándor Szilágyi, Marion P. Schwartz, Alena Kunzova +9 more
2003Psychiatry Research55 citations
Semantic Scholar
Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe.
D. Bugarski-Kirola, C. Arango, M. Fava, H. Nasrallah +3 more
2021Lancet psychiatry53 citations
Semantic Scholar
Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia
R. Keefe, G. Haig, S. Marder, Philip D. Harvey +21 more
2015Schizophrenia bulletin48 citations Open access
Semantic Scholar
Reliability, validity and ability to detect change of the PANSS negative symptom factor score in outpatients with schizophrenia on select antipsychotics and with prominent negative or disorganized thought symptoms.
Chris J. Edgar, T. Blaettler, D. Bugarski-Kirola, S. le Scouiller +2 more
2014Psychiatry Research37 citations
Semantic Scholar
Defining therapeutic benefit for people with schizophrenia: focus on negative symptoms.
N. Schooler, R. Buchanan, T. Laughren, S. Leucht +10 more
2015Schizophrenia Research34 citations
Semantic Scholar
ENHANCE: Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin for Schizophrenia in Patients With an Inadequate Response to Antipsychotic Treatment
D. Bugarski-Kirola, I. Bitter, I-Yuan Liu, Brandon Abbs +1 more
2022Schizophrenia Bulletin Open21 citations Open access
Semantic Scholar
Efficacy and safety of adjunctive bitopertin (5 and 10 mg) versus placebo in subjects with persistent predominant negative symptoms of schizophrenia treated with antipsychotics — Results from the phase III DayLyte study
C. Arango, H. Nasrallah, S. Lawrie, Tânia H. O. Lohmann +4 more
201412 citations
Semantic Scholar
P300 in schizophrenia
S. Filipović, D. Bugarski-Kirola, V. Paunović, V. Kostic
199412 citations
Semantic Scholar
Psychometric evaluation of the Work Readiness Questionnaire in schizophrenia
S. Potkin, D. Bugarski-Kirola, Chris J. Edgar, Sherif M. Soliman +4 more
2014CNS Spectrums11 citations Open access
Semantic Scholar
EFFICACY AND SAFETY OF ADJUNCTIVE BITOPERTIN VERSUS PLACEBO IN SUBJECTS WITH PERSISTENT PREDOMINANT NEGATIVE SYMPTOMS OF SCHIZOPHRENIA TREATED WITH ANTIPSYCHOTICS – UPDATE FROM THE SEARCHLYTE PROGRAMME
D. Bugarski-Kirola, C. Arango, W. Fleischhacker, R. Bressan +6 more
201410 citations
Semantic Scholar
Effects of adjunctive pimavanserin and current antipsychotic treatment on QT interval prolongation in patients with schizophrenia
D. Bugarski-Kirola, Rene Nunez, R. Odetalla, I. Liu +1 more
2022Frontiers in Psychiatry9 citations Open access
Semantic Scholar
Pimavanserin Exposure-Response Analyses in Patients With Schizophrenia
M. Darwish, D. Bugarski-Kirola, J. Passarell, J. Owen +3 more
2022Journal of Clinical Psychopharmacology7 citations Open access
Semantic Scholar
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pimavanserin as an Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE-2) in Patients With Predominant Negative Symptoms
D. Bugarski-Kirola, I-Yuan Liu, C. Arango, Stephen R. Marder
2025Schizophrenia bulletin6 citations Open access
Semantic Scholar
Population Pharmacokinetic Modeling and Stochastic Simulations to Support Pediatric Dose Selection of Pimavanserin
M. Darwish, D. Bugarski-Kirola, D. Jaworowicz, J. Owen +3 more
2023Journal of clinical pharmacology4 citations Open access
Semantic Scholar
P-29 Fluoxetine versus moclobemide in elderly depressed patients
D. Bugarski-Kirola, Dj. Živković, Z. Stankovic, A. Damjanović
19964 citations
Semantic Scholar
Conducting CNS trials during a public health emergency – Lessons learned from the COVID-19 pandemic: A joint ISCTM/ECNP working group consensus paper
K. Olugemo, D. Bugarski-Kirola, G. Dawson, F. DiCesare +7 more
2023Neuroscience Applied3 citations Open access
Semantic Scholar
T42. HIGH ADHERENCE TO CURRENT ANTIPSYCHOTIC AND ADJUNCTIVE PIMAVANSERIN IN THE ENHANCE STUDY, A PHASE 3 TRIAL TO EVALUATE THE TREATMENT OF SCHIZOPHRENIA IN PATIENTS WITH AN INADEQUATE RESPONSE TO ANTIPSYCHOTIC TREATMENT
B. Abbs, D. Bugarski-Kirola, I-Yuan Liu, M. Darwish +1 more
2020Schizophrenia bulletin3 citations Open access
Semantic Scholar
PRM30 Evaluating Readiness for Work in Patients With Schizophrenia: “The Readiness for Work Questionnaire” (WoRQ)
S. Potkin, D. Bugarski-Kirola, Chris J. Edgar, S. Luo
20123 citations Open access
Semantic Scholar
Adherence to Background Antipsychotic and Pimavanserin in Patients with Schizophrenia: Post Hoc Analyses from the ENHANCE and ADVANCE Studies
D. Bugarski-Kirola, Brandon Abbs, R. Odetalla, I. Liu +2 more
2024Patient Preference and Adherence2 citations Open access
Semantic Scholar
T41. SAFETY PROFILE OF ADJUNCTIVE PIMAVANSERIN IN THE ENHANCE STUDY, A PHASE 3 TRIAL FOR THE POTENTIAL TREATMENT OF SCHIZOPHRENIA IN PATIENTS WITH AN INADEQUATE RESPONSE TO ANTIPSYCHOTIC TREATMENT
D. Bugarski-Kirola, Rene Nunez, R. Odetalla, M. Bari +4 more
2020Schizophrenia bulletin2 citations Open access
Semantic Scholar
Memantine for the Treatment of Primary Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Controlled Trials
Hou-Lin Hong, Jack Donlon, Martin Schaefer, Susanne Sarkar +15 more
2025Clinical drug investigation1 citations
Semantic Scholar
P.0775 Adherence to background antipsychotic and pimavanserin in patients with schizophrenia: post hoc analyses from the ENHANCE and ADVANCE trials
D. Bugarski-Kirola, B. Abbs, R. Odetalla, I. Liu +3 more
2021European Neuropsychopharmacology1 citations
Semantic Scholar
PMH56 Negative Symptoms Have Greater Impact on Functioning Than Positive Symptoms in Schizophrenia: Analysis of Catie Data
J. Rabinowitz, George Garibaldi, S. Levine, D. Bugarski-Kirola +2 more
20111 citations Open access
Semantic Scholar
Pimavanserin for Irritability in Children and Adolescents With Autism Spectrum Disorder: Phase 2 Randomized Trial.
D. Bugarski-Kirola, R. Hofbauer, S. Sameljak, Elysa J. Marco +7 more
2026Journal of the American Academy of Child and Adolescent Psychiatry0 citations Open access
Semantic Scholar
Pimavanserin for the treatment of irritability associated with autism spectrum disorder in children and adolescents: a randomised, double-blind, placebo-controlled study
D. Bugarski-Kirola, R. K. Hofbauer, S. Sameljak, E. Marco +7 more
2026Neuroscience Applied0 citations Open access
Semantic Scholar
Comorbidities and behavioral issues.
D. Bugarski-Kirola, R. Marcus
2021European Neuropsychopharmacology0 citations
Semantic Scholar
P.0779 Relationship between pimavanserin exposure and QTc interval in patients with schizophrenia: modelling analysis from randomised, double-blind, placebo-controlled studies
M. Darwish, D. Bugarski-Kirola, J. Passarell, K. Maxwell +3 more
2021European Neuropsychopharmacology0 citations
Semantic Scholar
P.577 ADVANCE: phase 2, randomised, double-blind, placebo-controlled study of adjunctive pimavanserin in patients with negative symptoms of schizophrenia
D. Bugarski-Kirola, Celso Arango, M. Fava, H. Nasrallah +3 more
2020European Neuropsychopharmacology0 citations
Semantic Scholar
P.578 ENHANCE trial: adherence to current antipsychotic and adjunctive pimavanserin in patients with schizophrenia and inadequate response to antipsychotic treatment
B. Abbs, D. Bugarski-Kirola, I. Liu, M. Darwish +1 more
2020European Neuropsychopharmacology0 citations
Semantic Scholar
Validity and utility of the PANSS negative symptoms factor score as a clinical trial outcome
Chris J. Edgar, T. Blaettler, D. Bugarski-Kirola, S. le Scouiller +2 more
20140 citations
Semantic Scholar
Development of the readiness for work questionnaire in schizophrenia
S. Potkin, D. Bugarski-Kirola, Chris J. Edgar, S. le Scouiller +4 more
20130 citations Open access
Semantic Scholar
Reliability and Validity of the PANSS Negative Symptom Factor Score in Outpatients with Schizophrenia Prescribed Select Antipsychotics and with Prominent Negative or Disorganized Thought Symptoms
Chris J. Edgar, T. Blaettler, D. Bugarski-Kirola, S. le Scouiller +1 more
20130 citations
Semantic Scholar
Poster #184 EVALUATING READINESS FOR WORK AND USEFUL ACTIVITIES IN PATIENTS WITH SCHIZOPHRENIA: “THE READINESS FOR WORK QUESTIONNAIRE” WORQ
D. Bugarski-Kirola, S. Potkin, George Garibaldi
20120 citations
Semantic Scholar
Sulpiride Augmentation in refractory depression
Z. Stankovic, Dj. Živkovic-Milovanović, D. Bugarski-Kirola, A. Damjanović
19960 citations
Semantic Scholar
The Efficacy of Sulpiride in the Treatment of Negative Forms of Schizophrenia
D. Bugarski-Kirola, D. Živkovic-Milovanović, A. Damjanović, Z. Stankovic
1996European psychiatry0 citations
Semantic Scholar
The efficacy of sertraline in the treatment of major depression
D. Bugarski-Kirola, A. Damjanović, V. Paunović, Dj. Živković +1 more
19960 citations
Semantic Scholar
Transient global amnesia-possible aetiopathogenetic mechanisms
D. Bugarski-Kirola, C. Prokopljević, M. Kovacević
19960 citations
Semantic Scholar
P-12-36 – Dexamethasone suppression test in depression
D. Živkovic-Milovanović, D. Bugarski-Kirola, Z. Stankovic, A. Damjanović
19960 citations
Semantic Scholar
[Transient global amnesia--possible aetiopathogenetic mechanisms].
D. Bugarski-Kirola, C. Bugarski-Prokopljević, M. Kovačević
1995Srpski Arhiv za Celokupno Lekarstvo0 citations
Semantic Scholar
P-2-35 Efficacy of fluoxetine in comparison to maprotiline and amitriptyline in major depression with anxious features
D. Bugarski-Kirola, S. Totić, A. Damjanović, Dj. Živković
19950 citations
Semantic Scholar
P-2-122 Analysis of the Hamilton depression rating scale factors — fluoxetine vs. maprotiline
Stanković, Dj. ivković-Milovanović, D. Bugarski-Kirola, A. Damjanović
19950 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

George Garibaldi×13
Invite
George Garibaldi — researcher profile on SciRah
S. Stankovic×9
Invite
S. Stankovic — researcher profile on SciRah
T. Blaettler×7
Invite
T. Blaettler — researcher profile on SciRah
I. Liu×7
Invite
I. Liu — researcher profile on SciRah

×7

Invite

Chris J. Edgar — researcher profile on SciRah

A. Damjanović×7

Invite

A. Damjanović — researcher profile on SciRah

H. Nasrallah×6

Invite

H. Nasrallah — researcher profile on SciRah

Invite

S. Marder — researcher profile on SciRah

C. G. Berardo×5

Invite

C. G. Berardo — researcher profile on SciRah

Invite

B. Abbs — researcher profile on SciRah

S. le Scouiller×5

Invite

S. le Scouiller — researcher profile on SciRah

Z. Stankovic×5

Invite

Z. Stankovic — researcher profile on SciRah